FDA, Creditors Oppose Drugmaker Humanigen's Ch. 11 Sale

By Clara Geoghegan · February 13, 2024, 7:47 PM EST

Biopharmaceutical company Humanigen faced fire on multiple fronts Tuesday after it asked the Delaware bankruptcy court to approve a $2 million stalking horse credit bid from its debtor-in-possession lender, an entity...

To view the full article, register now.